Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ovid Therapeutics (OVID) had Debt to Capital Ratio of 0.22 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.13M |
|
$-12.16M |
|
-- |
|
$0.13M |
|
$12.65M |
|
$-12.52M |
|
$0.36M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-12.16M |
|
$-12.52M |
|
$-12.51M |
|
71.11M |
|
71.11M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$28.82M |
|
$0.27M |
|
$35.02M |
|
$63.85M |
|
$6.80M |
|
$12.35M |
|
$12.35M |
|
$19.15M |
|
$44.70M |
|
$44.70M |
|
$44.70M |
|
71.15M |
|
| Cash Flow Statement Financials | |
$-27.93M |
|
$22.21M |
|
$0.03M |
|
$28.23M |
|
$22.54M |
|
$-5.69M |
|
$3.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.24 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.22 |
0.31 |
|
100.00% |
|
-9487.12% |
|
-9487.12% |
|
-- |
|
-9210.61% |
|
-9210.61% |
|
$-27.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-27.20% |
|
-27.20% |
|
-19.04% |
|
-21.31% |
|
$0.63 |
|
$-0.39 |
|
$-0.39 |
|